Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP

Blood

Volumn 114, Issue 21, 2009, Pages 4729-4737

  Falet, Hervé ^a   Marchetti, Michael P ^a   Hoffmeister, Karin M ^a   Massaad, Michel J ^a   Geha, Raif S ^a   Hartwig, John H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; GLYCOPROTEIN VI; IMMUNOGLOBULIN A; PHOSPHOLIPASE C GAMMA2; PROTEIN; PROTEIN WIP; UNCLASSIFIED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN; CARRIER PROTEIN; FIBRINOGEN RECEPTOR; PLATELET MEMBRANE GLYCOPROTEIN VI; WASPIP PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM MOBILIZATION; CELL SURVIVAL; CONTROLLED STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; ANIMAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; THROMBOCYTE; WESTERN BLOTTING;

ANIMALS; BLOOD PLATELETS; BLOTTING, WESTERN; CARRIER PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOGLOBULIN A; MICE; MICE, KNOCKOUT; PLATELET MEMBRANE GLYCOPROTEINS; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 73949146436     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-202721     Document Type: Article

References (51)

1. Ochs HD, Thrasher AJ. The Wiskott-Aldrich Syndrome. J Allergy Clin Immunol. 2006;117(4):725-738.
2. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich Syndrome. Cell. 1994;78(4):635-644.
3. Kwan S-P, Hageman TL, Radtke BE, Blaese RM, Rosen FS. Identification of mutations in the Wiskott-Aldrich Syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc Natl Acad Sci U S A. 1995;92(10):4706-4710.
4. Symons M, Derry JMJ, Kariak B, et al. Wiskott-Aldrich Syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 1996;84(5):723-734.
5. Yarar D, To W, Abo A, Welch MD. The Wiskott-Aldrich Syndrome protein directs actin-based motility by stimulating actin nucleation with the Arp2/3 complex. Curr Biol. 1999;9(10):555-558.
6. Higgs HN, Pollard TD. Activation by Cdc42 and PIP2 of Wiskott-Aldrich Syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. J Cell Biol. 2000;150(6):1311-1320.
7. Sasahara Y, Rachid R, Byrne MJ, et al. Mechanism of recruitment of WASp to the immunological synapse and of its activation following TCR ligation. Mol Cell. 2002;10(6):1269-1281.
8. Badour K, Zhang J, Shi F, Leng Y, Collins M, Siminovitch KA. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich Syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J Exp Med. 2004;199(1):99-112.
9. Murphy S, Oski FA, Naiman JL, Lusch CJ, Goldberg S, Gardner FH. Platelet size and kinetics in hereditary and acquired thrombocytopenia. N Engl J Med. 1972;286(10):499-504.
10. Corash L, Shafer B, Blaese RM. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood. 1985;65(6):1439-1443.
11. Mullen CA, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood. 1993; 82(10):2961-2966.
12. Semple JW, Siminovitch KA, Mody M, et al. Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure. Br J Haematol. 1997;97(4):747-754.
13. Haddad E, Cramer E, Rivière C, et al. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. Blood. 1999;94(2):509-518.
14. Snapper SB, Rosen FS, Nizoguchi E, et al. Wiskott-Aldrich Syndrome protein-deficient mice reveal a role for WASp in T but not B cell activation. Immunity. 1998;9(1):81-91.
15. Zhang J, Shehabeldin A, da Cruz LA, et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich Syndrome protein-deficient lymphocytes. J Exp Med. 1999;190(9):1329-1342.
16. Sabri S, Foudi A, Boukour S, et al. Deficiency in the Wiskott Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment. Blood. 2006; 108(1):134-140.
17. Oda A, Ochs HD, Druker BJ, et al. Collagen induces tyrosine phosphorylation of Wiskott-Aldrich Syndrome protein in human platelets. Blood. 1998;92(6):1852-1858.
18. Gross BS, Wilde JI, Quek L, Chapel H, Nelson DL, Watson SP. Regulation and function of WASp in platelets by the collagen receptor glycoprotein VI. Blood. 1999;94(12):4166-4176.
19. Oda A, Ochs HD, Lasky LA, et al. CrkL is an adapter for Wiskott-Aldrich Syndrome protein and Syk. Blood. 2001;97(9):2633-2639.
20. Krause M, Sechi AS, Konradt M, Monner D, Gertler FB, Wehland J. Fyn-binding protein (Fyb)/ SLP-76-associated protein (SLAP), Ena/ Vasodilatator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J Cell Biol. 2000;149(1):181-194.
21. Obergfell A, Judd BA, del Pozo MA, Schwartz MA, Koretzky GA, Shattil SJ. The molecular adapter SLP-76 relays signals from platelet integrin αIIbβ3 to the actin cytoskeleton. J Biol Chem. 2001;276(8):5916-5923.
22. Falet H, Hoffmeister KM, Neujahr R, Hartwig JH. Normal Arp2/3 complex activation in platelets lacking WASp. Blood. 2002;100(6):2113-2122.
23. Ramesh N, Antón IM, Hartwig JH, Geha RS. WIP, a protein associated with Wiskott-Aldrich Syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci U S A. 1997;94(26):14671- 14676.
24. Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA. Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell. 2002;111(4):565-576.
25. Moreau V, Frischknecht F, Reckmann I, et al. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat Cell Biol. 2000;2(7):441-448.
26. Martinez-Quiles N, Rohatgi R, Antón IM, et al. WIP regulates N-WASP-mediated actin polymerization and filopodium formation. Nat Cell Biol. 2001;3(5):484-491.
27. Kinley AW, Weed SA, Weaver AM, et al. Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion. Curr Biol. 2003;13(5): 384-393.
28. Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N, Geha RS. Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol. 2004;24(12):5269-5280.
29. Stewart DM, Tian L, Nelson DL. Mutations that cause the Wiskott-Aldrich Syndrome impair the interaction of Wiskott-Aldrich Syndrome protein (WASp) with WASp interacting protein. J Immunol. 1999;162(8):5019-5024.
30. Luthi JN, Gandhi MJ, Drachman JG. X-linked thrombocytopenia caused by a mutation in the Wiskott-Aldrich Syndrome (WAS) gene that disrupts interaction with the WAS protein (WASp)-interacting protein (WIP). Exp Hematol. 2003; 31(2):150-158.
31. Lutskiy MI, Rosen FS, Remold-O'Donnell E. Genotype-proteotype linkage in the Wiskott-Aldrich syndrome. J Immunol. 2005;175(2):1329-1336.
32. Antón IM, de la Fuente MA, Sims TN, et al. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity. 2002;16(2):193-204.
33. Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin α2β1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for α2β1-independent platelet reactivity. Biochem J. 1995;306(2):337-344.
34. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell. 2003;112(1):87-97.
35. Bergmeier W, Burger PC, Piffath CL, et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood. 2003;102(12):4229-4235.
36. Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin alphaIIbbeta3 signaling in platelets. J Thromb Haemost. 2005;3(8):1752-1762.
37. Wang D, Feng J, Wen R, et al. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity. 2000;13(1): 25-35.
38. Nieswandt B, Schulte V, Bergmeier W, et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med. 2001;193(4):459-469.
39. Massberg S, Gawaz M, Grüner S, et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med. 2003; 197(1):41-49.
40. Boylan B, Chen H, Rathore V, et al. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. Blood. 2004;104(5): 1350-1355.
41. Soriani A, Moran B, de Virgilio M, et al. A role for PKCθ in outside-in αIIbβ3 signaling. J Thromb Haemost. 2006;4(3):648-655.
42. Koduru S, Massaad M, Wilbur C, Kumar L, Geha R, Ramesh N. A novel anti-WIP monoclonal antibody detects an isoform of WIP that lacks the WASP binding domain. Biochem Biophys Res Commun. 2007;353(4):875-881.
43. Krzewski K, Chen X, Orange JS, Strominger JL. Formation of a WIP-, WASp-, actin-, and myosin IIA-containing multiprotein complex in activated NK cells and its alteration by KIR inhibitory signaling. J Cell Biol. 2006;173(1):121-132.
44. de la Fuente MA, Sasahara Y, Calamito M, et al. WIP is a chaperone for Wiskott-Aldrich Syndrome protein (WASP). Proc Natl Acad Sci U S A. 2007; 104(3):926-931.
45. Konno A, Kirby M, Anderson SA, Schwartzberg PL, Candotti F. The expression of Wiskott-Aldrich Syndrome protein (WASP) is dependent on WASP-interacting protein (WIP). Int Immunol. 2007;19(2):185-192.
46. Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Pathol. 2006;208(2):270-282.
47. Curcio C, Pannellini T, Lanzardo S, Forni G, Musiani P, Antón I. WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome. J Pathol. 2007;211(1): 67-75.
48. De Santo N, Sessa A, Capodicasa G, et al. IgA glomerulonephritis in Wiskott-Aldrich syndrome. Child Nephrol Urol. 1989;9(1):118-120.
49. Matsukura H, Kanegane H, Miya K, et al. IgA nephropathy associated with X-linked thrombocytopenia. Am J Kidney Dis. 2004;43(3):e7-e12.
50. Kettner A, Kumar L, Antón IM, et al. WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells. J Exp Med. 2004; 199(3):357-368.
51. Shcherbina A, Rosen FS, Remold-O'Donnell E. Pathological events in platelets of Wiskott-Aldrich syndrome patients. Br J Haematol. 1999;106(4): 875-883.